Literature DB >> 24922169

Mortality from sexually transmitted diseases in reproductive-aged women: United States, 1999-2010.

Kara A McElligott1.   

Abstract

OBJECTIVES: I estimated the sexually transmitted disease-related mortality among US reproductive-aged women from 1999 to 2010.
METHODS: I estimated mortality from National Center for Health Statistics' Multiple Cause of Death data. I defined reproductive age as 15 to 44 years. For diseases partially caused by sexual transmission, I estimated the proportion attributable to sexual transmission from the literature. To calculate mortality rates, I estimated number of deaths from each disease and Census Bureau population for reproductive-aged women for 1999 to 2010.
RESULTS: From 1999 to 2010, the cumulative sexually transmitted disease-related mortality rate decreased by 49%, from 5.3 to 2.7 deaths per 100 000. The primary contributors were HIV and human papilloma virus infections. Mortality from sexually transmitted HIV infection decreased by 62%, from 3.4 to 1.3 deaths per 100 000. Mortality from human papilloma virus-associated gynecologic cancers decreased by 19%, from 1.6 deaths per 100 000 in 1999 to 1.3 deaths per 100 000 in 2010.
CONCLUSIONS: Screening and treatment for sexually transmitted diseases may reduce mortality. Research is needed to determine whether sexually transmitted disease-related morbidity among reproductive-aged women has decreased over the past decade.

Entities:  

Mesh:

Year:  2014        PMID: 24922169      PMCID: PMC4103235          DOI: 10.2105/AJPH.2014.302044

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  35 in total

1.  Mortality related to sexually transmitted diseases in US women, 1973 through 1992.

Authors:  S H Ebrahim; T A Peterman; A A Zaidi; M L Kamb
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

2.  The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study.

Authors:  J M Chow; M L Yonekura; G A Richwald; S Greenland; R L Sweet; J Schachter
Journal:  JAMA       Date:  1990-06-20       Impact factor: 56.272

3.  Sexually transmitted diseases and tubal pregnancy.

Authors:  K J Sherman; J R Daling; A Stergachis; N S Weiss; H M Foy; S P Wang; J T Grayston
Journal:  Sex Transm Dis       Date:  1990 Jul-Sep       Impact factor: 2.830

4.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

5.  Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study.

Authors:  G Ingrid J G Rours; Liesbeth Duijts; Henriette A Moll; Lidia R Arends; Ronald de Groot; Vincent W Jaddoe; Albert Hofman; Eric A P Steegers; Johan P Mackenbach; Alewijn Ott; Hendrina F M Willemse; Elizabeth A E van der Zwaan; Roel P Verkooijen; Henri A Verbrugh
Journal:  Eur J Epidemiol       Date:  2011-05-03       Impact factor: 8.082

Review 6.  The epidemiology of genital human papillomavirus infection.

Authors:  Helen Trottier; Eduardo L Franco
Journal:  Vaccine       Date:  2006-03-30       Impact factor: 3.641

7.  Surveillance for acute viral hepatitis--United States, 2006.

Authors:  Annemarie Wasley; Scott Grytdal; Kathleen Gallagher
Journal:  MMWR Surveill Summ       Date:  2008-03-21

8.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

9.  Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.

Authors:  S Deblina Datta; Laura A Koutsky; Sylvie Ratelle; Elizabeth R Unger; Judith Shlay; Tracie McClain; Beth Weaver; Peter Kerndt; Jonathan Zenilman; Michael Hagensee; Cristen J Suhr; Hillard Weinstock
Journal:  Ann Intern Med       Date:  2008-04-01       Impact factor: 25.391

10.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

View more
  4 in total

1.  A Qualitative Systematic Review of Women's Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies.

Authors:  Sara E Vargas; Miriam M Midoun; Melissa Guillen; Melissa L Getz; Kristen Underhill; Caroline Kuo; Kate M Guthrie
Journal:  Perspect Sex Reprod Health       Date:  2019-05-20

2.  HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006-2013.

Authors:  Lin Chen; Xiaohong Pan; Qiaoqin Ma; Jiezhe Yang; Yun Xu; Jinlei Zheng; Hui Wang; Xin Zhou; Tingting Jiang; Jun Jiang; Lin He; Jianmin Jiang
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

3.  Screening for chlamydia and/or gonorrhea in primary health care: protocol for systematic review.

Authors:  Jennifer Pillay; Ainsley Moore; Prinon Rahman; Gabriel Lewin; Donna Reynolds; John Riva; Guyléne Thériault; Brett Thombs; Brenda Wilson; Joan Robinson; Amanda Ramdyal; Geneviéve Cadieux; Robin Featherstone; Anne N Burchell; Jo-Anne Dillon; Ameeta Singh; Tom Wong; Marion Doull; Greg Traversy; Susan Courage; Tara MacGregor; Cydney Johnson; Ben Vandermeer; Lisa Hartling
Journal:  Syst Rev       Date:  2018-12-26

4.  Screening for chlamydia and/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences.

Authors:  Jennifer Pillay; Aireen Wingert; Tara MacGregor; Michelle Gates; Ben Vandermeer; Lisa Hartling
Journal:  Syst Rev       Date:  2021-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.